V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290008005 | 290005542 | 0 | 65.7 | Curative (C) | 2017-08-24 | 2017-08-24 | MITOMYCIN | N | N | 290022648 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008006 | 290005546 | 1.64 | 52.2 | Curative (C) | 2017-06-27 | 2017-06-30 | Cisplatin + Radiotherapy | 2 | Y | 290022654 | CARBOPLATIN |
| 290008007 | 290005548 | 0 | 92.2 | Palliative (P) | 2014-03-12 | 2014-04-09 | Capecitabine | null | N | 290022661 | CETUXIMAB + MDG |
| 290008008 | 290005549 | null | 65.1 | Adjuvant (A) | 2018-02-17 | 2018-03-14 | Cetuximab + Radiotherapy Maint | N | N | 290022662 | BORTEZOMIB |
| 290008009 | 290005552 | 1.61 | 83 | Palliative (P) | 2017-11-13 | 2017-11-13 | Capecitabine (21 day) + Irinotecan | 02 | N | 290022684 | SUNITINIB |
| 290008010 | 290007356 | null | 91 | Palliative (P) | 2014-09-24 | 2014-10-01 | Cetuximab + FOLFIRI cycle1 | N | N | 290022722 | CETUXIMAB + CISPLATIN + FU |
| 290008011 | 290007357 | null | 67.2 | Adjuvant (A) | 2018-04-17 | 2018-05-11 | Ipilimumab | 2 | N | 290022734 | CISPLATIN + RT |
| 290008012 | 290005559 | 1.87 | 62.9 | Palliative (P) | 2013-09-20 | 2013-09-20 | CAPECITABINE + CARBOPLATIN | 02 | N | 290022737 | EVEROLIMUS |
| 290008013 | 290005559 | 1.69 | 83 | Palliative (P) | null | 2015-03-05 | Capecitabine | N | N | 290022737 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290008014 | 290005564 | 1.56 | 60.2 | Palliative (P) | 2018-07-23 | 2018-08-02 | LANREOTIDE | N | null | 290022763 | PACLITAXEL |
| 290008015 | 290005567 | 1.73 | 0 | Palliative (P) | 2015-09-13 | 2015-10-10 | Capecitabine 35days + RT | 1 | N | 290022776 | TRASTUZUMAB + VINORELBINE |
| 290008016 | 290005567 | 1.58 | null | Palliative (P) | 2018-03-24 | 2018-03-24 | Cisplatin 7 day | N | null | 290022776 | CARBOPLATIN + PACLITAXEL |
| 290008017 | 290005569 | null | 85 | Palliative (P) | 2016-03-25 | 2016-03-25 | MITOMYCIN | 02 | N | 290000136 | CETUXIMAB |
| 290008018 | 290005572 | 1.75 | null | Curative (C) | 2016-12-16 | 2017-01-11 | Sunitinib | Y | Y | 290000851 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008019 | 290005576 | null | 88 | Not known (9) | 2016-09-01 | 2017-04-05 | Rituximab | 02 | null | 290001592 | FLUOROURACIL + MITOMYCIN |
| 290008020 | 290005581 | 1.86 | 84.4 | Curative (C) | 2019-11-18 | 2019-11-23 | LANREOTIDE | 02 | Y | 290002606 | R CODOX M |
| 290008021 | 290005583 | 1.6 | null | Palliative (P) | 2018-07-04 | 2018-10-20 | FLUOROURACIL + MITOMYCIN | 02 | N | 290003147 | INTERAACT TRIAL |
| 290008022 | 290005586 | 1.6 | 76.2 | Curative (C) | 2015-01-13 | 2015-01-13 | CompARE Trial | N | N | 290004877 | CARBOPLATIN |
| 290008023 | 290005588 | 1.59 | 55.6 | Palliative (P) | 2014-06-10 | 2014-06-11 | LANREOTIDE | 2 | N | 290006785 | CAPECITABINE + CISPLATIN |
| 290008024 | 290005591 | 1.77 | 55 | Palliative (P) | 2016-10-12 | 2016-10-12 | Capecitabine | 02 | N | 290007714 | CETUXIMAB + CISPLATIN + FU |
| 290008025 | 290005594 | 1.72 | 51.5 | Curative (C) | 2015-02-27 | 2015-03-20 | Docetaxel 100mg/m2 (21 day) | N | N | 290008739 | CARBOPLATIN |
| 290008026 | 290005596 | 0 | null | Palliative (P) | null | 2018-12-23 | Capecitabine | 2 | N | 290008801 | CAPECITABINE + IRINOTECAN |
| 290008027 | 290005599 | null | 84.3 | Curative (C) | 2017-09-05 | 2017-10-07 | OCTREOTIDE | N | null | 290010012 | VDC |
| 290008028 | 290005601 | null | 69.2 | Palliative (P) | 2018-12-02 | 2018-12-16 | Sunitinib | N | N | 290010190 | PCV |
| 290008029 | 290005602 | 1.8 | null | Palliative (P) | 2017-05-13 | 2017-06-10 | Carboplatin + Etoposide iv&po | N | null | 290010785 | CAPECITABINE |
| 290008030 | 290005604 | 1.6 | 72.4 | Curative (C) | 2018-09-05 | 2018-10-06 | Cisplatin + Radiotherapy | N | N | 290011095 | MITOMYCIN |
| 290008031 | 290005607 | 0 | 67.2 | Palliative (P) | null | 2016-06-27 | Capecitabine + Oxaliplatin 21day | N | N | 290011395 | TEMOZOLOMIDE |
| 290008032 | 290005607 | null | null | Palliative (P) | 2018-01-29 | 2018-03-02 | Cisplatin 7 day | N | N | 290011395 | CAPECITABINE + IRINOTECAN |
| 290008033 | 290005612 | 1.63 | 67.55 | Palliative (P) | 2018-01-11 | 2018-01-11 | CARBOPLATIN + RT | N | N | 290013542 | SUNITINIB |
| 290008034 | 290007383 | 1.63 | 79.3 | Palliative (P) | 2017-03-22 | 2017-07-11 | CISPLATIN + RT | 02 | N | 290013573 | CAPECITABINE + OXALIPLATIN |
| 290008035 | 290008065 | 1.6 | 64.7 | Curative (C) | 2016-08-18 | 2016-09-18 | Cisplatin 100 + RT(H&N) 1 day | null | N | 290015077 | CAPECITABINE + OXALIPLATIN |
| 290008036 | 290005621 | null | null | Curative (C) | 2014-02-25 | 2014-03-06 | Carboplatin + Etoposide iv&po | null | null | 290015201 | TRASTUZUMAB |
| 290008037 | 290005629 | 1.7 | 48.3 | Disease modification (D) | 2019-01-07 | 2019-01-09 | Irinotecan | 02 | N | 290015541 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 290008038 | 290005630 | 1.79 | 0 | Adjuvant (A) | 2017-04-29 | 2017-05-31 | EOX | 02 | N | 290015867 | RUXOLITINIB |
| 290008039 | 290005635 | 1.79 | 56.9 | Disease modification (D) | 2019-09-14 | 2019-09-17 | Capecitabine + Cisplatin | N | N | 290017317 | CISPLATIN + RT |
| 290008040 | 290005636 | 1.59 | 60 | Palliative (P) | 2018-09-21 | 2018-09-27 | Carboplatin + Etoposide iv&po | 02 | N | 290017352 | DOCETAXEL |
| 290008041 | 290005638 | 1.58 | 78.9 | Palliative (P) | 2013-11-17 | 2013-12-29 | Sunitinib | N | N | 290017510 | IBRUTINIB |
| 290008042 | 290005639 | 1.84 | 81.6 | Palliative (P) | 2016-04-11 | 2016-04-29 | CETUXIMAB + OXALIPLATIN + MDG | N | N | 290017690 | DOCETAXEL + NINTEDANIB |
| 290008043 | 290005643 | null | null | Disease modification (D) | 2018-02-07 | 2018-02-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290018498 | LANREOTIDE |
| 290008044 | 290005645 | 1.73 | 66.5 | Adjuvant (A) | null | 2018-08-28 | Capecitabine + Oxaliplatin 21day | 02 | N | 290019493 | DOCETAXEL |
| 290008045 | 290005647 | 1.71 | null | Curative (C) | 2014-08-17 | 2014-08-23 | ECX | N | N | 290019536 | CETUXIMAB |
| 290008046 | 290005648 | 1.67 | 81 | Curative (C) | 2018-05-21 | 2018-05-21 | Docetaxel 75mg/m2 (21 day) | 2 | N | 290019567 | FLUOROURACIL + MITOMYCIN |
| 290008047 | 290005651 | 1.79 | 87 | Palliative (P) | 2018-10-18 | 2018-11-13 | PCV | N | N | 290020171 | MITOMYCIN |
| 290008048 | 290005655 | null | 103.4 | Palliative (P) | 2016-04-06 | 2016-04-06 | CETUXIMAB | 02 | N | 290020477 | PACLITAXEL |
| 290008049 | 290005657 | null | 92.3 | Palliative (P) | 2019-06-01 | 2019-06-15 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 290020732 | CAPECITABINE + CARBOPLATIN |
| 290008050 | 290005662 | 1.73 | null | Palliative (P) | 2016-04-23 | 2016-08-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | 290020936 | CAPECITABINE |
| 290008051 | 290005664 | 1.48 | null | Palliative (P) | 2019-02-02 | 2019-02-03 | CARBOPLATIN + FLUOROURACIL | 02 | N | 290021044 | NOT MATCHED |
| 290008052 | 290008072 | 1.78 | 84 | Palliative (P) | 2015-12-12 | 2015-12-12 | OCTREOTIDE | N | N | 290021601 | CAPECITABINE + MITOMYCIN + RT |
| 290008053 | 290005671 | 1.55 | 76.3 | Curative (C) | 2015-08-19 | 2015-09-01 | CARBOPLATIN + PACLITAXEL | N | N | 290021740 | MITOMYCIN |
| 290008054 | 290005674 | 1.64 | null | Adjuvant (A) | 2019-01-17 | 2019-02-04 | CISPLATIN + RT | 02 | N | 290021884 | CAPECITABINE + OXALIPLATIN |